Gene variants that protect against glaucoma identified, opening therapeutic possibilities
Glaucoma Acute angle closure glaucoma of the right eye (intraocular pressure was 42 in the right eye). Credit: James Heilman, MD/Wikipedia
An international research collaboration led by researchers from the University of Helsinki and Stanford University has identified rare changes in a gene called ANGPTL7 that lower intraocular pressure and significantly reduce the risk of glaucoma. The results open impor… 更多Gene variants that protect against glaucoma identified, opening therapeutic possibilities
Glaucoma Acute angle closure glaucoma of the right eye (intraocular pressure was 42 in the right eye). Credit: James Heilman, MD/Wikipedia
An international research collaboration led by researchers from the University of Helsinki and Stanford University has identified rare changes in a gene called ANGPTL7 that lower intraocular pressure and significantly reduce the risk of glaucoma. The results open important new therapeutic possibilities.
Scientists find evidence of link between diesel exhaust, risk of Parkinson's
UCLA’s Dr. Jeff Bronstein and his colleagues demonstrated how air pollutants can contribute to the buildup of toxic proteins in the brain. Credit: University of California, Los Angeles
A new UCLA study in zebrafish has identified the process by which air pollution can damage brain cells, potentially contributing to Parkinson's disease.
New trial platform could accelerate finding a cure for Parkinson's disease
Multi-Arm Multi-Stage (MAMS). Credit: IOS Press
Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease (PD). In the Journal of Parkinson's Disease scientists report on the possibility of using a multi-arm, multi-stage (MAMS) trial platform to evaluate several potential therapies at once, using lessons learned from other diseases.
#MultiArm … 更多New trial platform could accelerate finding a cure for Parkinson's disease
Multi-Arm Multi-Stage (MAMS). Credit: IOS Press
Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease (PD). In the Journal of Parkinson's Disease scientists report on the possibility of using a multi-arm, multi-stage (MAMS) trial platform to evaluate several potential therapies at once, using lessons learned from other diseases.
Novel treatment using patient's own cells opens new possibilities to treat Parkinson's disease
Novel treatment using patient's own cells opens new possibilities to treat Parkinson's disease Thanks to exciting novel therapies, there's hope on the horizon for individuals and families affected by Parkinson's disease. Credit: McLean Hospital
Reprogramming a patient's own skin cells to replace cells in the brain that are progressively lost during Parkinson's disease (PD) has been shown to be techni… 更多Novel treatment using patient's own cells opens new possibilities to treat Parkinson's disease
Novel treatment using patient's own cells opens new possibilities to treat Parkinson's disease Thanks to exciting novel therapies, there's hope on the horizon for individuals and families affected by Parkinson's disease. Credit: McLean Hospital
Reprogramming a patient's own skin cells to replace cells in the brain that are progressively lost during Parkinson's disease (PD) has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) in the most recent issue of the New England Journal of Medicine.
The number of people with COVID-19 continues to rise across the globe. Although most cases are mild, some people may experience more severe symptoms and require hospitalization. It is important that treatment is found to help people recover from critical cases of COVID-19, as some people cannot fight off the virus easily. This will help improve patient outcomes and prevent excess strain on crowded hospitals until a vaccine for COVID-19 is develo… 更多Investigating the use of anakinra for COVID-19
The number of people with COVID-19 continues to rise across the globe. Although most cases are mild, some people may experience more severe symptoms and require hospitalization. It is important that treatment is found to help people recover from critical cases of COVID-19, as some people cannot fight off the virus easily. This will help improve patient outcomes and prevent excess strain on crowded hospitals until a vaccine for COVID-19 is developed.
The global Hepatitis B Treatment Market is positioned for consistent growth, with market valuation expected to increase from USD 4.5 billion in 2023 to USD 7.3 billion by 2032, growing at a CAGR ...
shared news
